|
POLR1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.186000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.702000E-02 |
| Normal-vs-Stage2 |
2.573000E-01 |
| Normal-vs-Stage3 |
2.591700E-02 |
| Normal-vs-Stage4 |
1.950430E-02 |
| Stage1-vs-Stage2 |
6.744200E-01 |
| Stage1-vs-Stage3 |
4.800000E-01 |
| Stage1-vs-Stage4 |
4.391800E-01 |
| Stage2-vs-Stage3 |
4.018600E-01 |
| Stage2-vs-Stage4 |
3.790400E-01 |
| Stage3-vs-Stage4 |
9.337600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.137800E-02 |
| Normal-vs-AfricanAmerican |
9.644100E-02 |
| Normal-vs-Asian |
3.498200E-02 |
| Caucasian-vs-AfricanAmerican |
2.551700E-04 |
| Caucasian-vs-Asian |
6.862200E-01 |
| AfricanAmerican-vs-Asian |
4.064300E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.379100E-03 |
| Normal-vs-Female |
8.474100E-02 |
| Male-vs-Female |
5.260000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.425700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.362400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.108400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.068000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.691400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.303200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.241400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.846400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.685800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.449800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.623600E-02 |
| Classical-VS-Follicular |
1.076140E-02 |
| Classical-VS-Other |
1.941790E-01 |
| Classical-VS-Normal |
2.025800E-01 |
| Tall-VS-Follicular |
9.662400E-01 |
| Tall-VS-Other |
6.731600E-01 |
| Tall-VS-Normal |
1.482350E-02 |
| Follicular-VS-Other |
6.787600E-01 |
| Follicular-VS-Normal |
4.595100E-03 |
| Other-VS-Normal |
6.109900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.250400E-02 |
| Normal-vs-N1 |
3.978300E-03 |
| N0-vs-N1 |
1.647610E-01 |
|
|
